Last reviewed · How we verify
NCT03958604
Burst Neurostimulation for Discogenic Low Back Pain
NA trial testing Neurostimulation in Discogenic Pain in 16 participants. Completed in 31 December 2021.
31 December 2021
Quick facts
| Lead sponsor | Rijnstate Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 16 |
| Start date | 28 May 2019 |
| Primary completion | 31 December 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Neurostimulation
Conditions studied
- Discogenic Pain — all drugs for Discogenic Pain →
- Low Back Pain — all drugs for Low Back Pain →
Sponsor
Rijnstate Hospital
Who can join
Adults 18 to 65, any sex, with Discogenic Pain or Low Back Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this prospective post market pilot study is to evaluate the effect of Burst Spinal Cord Stimulation(B-SCS) in the management of chronic discogenic pain in subjects who are refractory to other available treatments. Selected subjects will not be suitable candidates for lumbar spinal surgery and will meet the standard selection process for SCS as routinely utilized in the study centers. Results from this pilot study will inform current clinical practice and future comparative studies in this specific population. Eligible subjects for B-SCS will be asked to participate in this study. If they decide to participate, they will be treated with the Prodigy TM and Proclaim TM (Abbott Laboratories) SCS system and prospectively followed for 12 months following implantation.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Burst Spinal Cord Stimulation as Compared With L2 Dorsal Root Ganglion Stimulation in Pain Relief for Nonoperated Discogenic Low Back Pain: Analysis of Two Prospective Studies.
Mons MR, Chapman KB, Terwiel C, Joosten EA, et al · · 2024 · cited 3× · PMID 37191612 · DOI 10.1016/j.neurom.2023.04.464
Verify or expand the search:
- PubMed search for NCT03958604
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Neurostimulation
Trials testing the same drug.
- NCT07015775 — Evaluation of the Analgesic Efficacy of an Ultrasound-guided Transperineal Pudendal Block in Outpatient Hemorrhoidal Sur · NA · not yet recruiting
- NCT07079215 — Evaluation of a Physical Device for Medical Use (ADTPM 1) for Opioid Withdrawal Symptoms · NA · recruiting
- NCT06013956 — Personalized Real-Time DBS and PD Mechanisms · Phase 4 · recruiting
- NCT06141668 — Optimal Stimulation Parameters to Disrupt Epileptiform Activity · NA · recruiting
- NCT05756894 — Neurostimulation for Respiratory Function After Spinal Cord Injury · NA · recruiting
Other recruiting trials for Discogenic Pain
Currently open trials in the same condition.
- NCT06345690 — VIA Disc NP Registry 3.0 · recruiting
- NCT06372054 — TORNADO-Omics Techniques and Neural Networks for the Development of Predictive Risk Models · recruiting
Other Rijnstate Hospital trials
Trials by the same sponsor.
- NCT07070583 — Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure · NA · recruiting
- NCT07304401 — Evaluation of Effectiveness of Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy for Treatment of Chemotherapy Induce · recruiting
- NCT06883591 — Triaxial Accelerometry Study · active not recruiting
- NCT06827509 — Blood Flow Evaluation After Carotid Surgical Treatment · not yet recruiting
- NCT05633550 — Flexion-Extension Radiograph Imaging Protocol Reliability Study · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03958604 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rijnstate Hospital
- Last refreshed: 19 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03958604.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing